Cancer (neoplasms): Rectum
Conditions
Interventions
Monitoring of carcinoembryonic antigen (CEA) in primary care vs intensive imaging in hospital.
Follow-up after 3 months.
See details of ISRCTN41458548: FACS main trial on http://www.controlled-trials
Sponsors
Department of Health (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who have undergone resection for colorectal cancer with curative intent.
Exclusion criteria
Exclusion criteria: Not provided at time of registration.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Not provided at time of registration. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration. | — |
Countries
United Kingdom
Outcome results
None listed